Health knowledge made personal
Join this community!
› Share page:
Search posts:

FDA Drug Safety Communication: Selective Serotonin Reuptake Inhibitor (Ssri) Antidepressant Use During Pregnancy And Reports Of

Posted Dec 14 2011 6:21pm

The U.S. Food and Drug Administration (FDA) is updating the public on the use of selective serotonin reuptake inhibitor (SSRI) antidepressants by women during pregnancy and the potential risk of a rare heart and lung condition known as persistent pulmonary hypertension of the newborn (PPHN). The initial Public Health Advisory in July 2006 on this potential risk was based on a single published study.  Since then, there have been conflicting findings from new studies evaluating this potential risk, making it unclear whether use of SSRIs during pregnancy can cause PPHN.

Post a comment
Write a comment:

Related Searches